Tumor-driven Molecular Changes in Human Mesenchymal Stromal Cells
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hanahan D, Coussens LM (2012) Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 21(3):309–322. doi: 10.1016/j.ccr.2012.02.022
Kucerova L, Skolekova S (2013) Tumor microenvironment and the role of mesenchymal stromal cells. Neoplasma 60(1):1–10. doi: 10.4149/neo_2013_001
Kidd S, Spaeth E, Dembinski JL, Dietrich M, Watson K, Klopp A, Battula VL, Weil M, Andreeff M, Marini FC (2009) Direct evidence of mesenchymal stem cell tropism for tumor and wounding microenvironments using in vivo bioluminescent imaging. Stem Cells 27(10):2614–2623. doi: 10.1002/stem.187
Kidd S, Spaeth E, Watson K, Burks J, Lu H, Klopp A, Andreeff M, Marini FC (2012) Origins of the tumor microenvironment: quantitative assessment of adipose-derived and bone marrow-derived stroma. PLoS One 7(2):e30563. doi: 10.1371/journal.pone.0030563
Keating A (2012) Mesenchymal stromal cells: new directions. Cell Stem Cell 10(6):709–716. doi: 10.1016/j.stem.2012.05.015
Le Blanc K, Mougiakakos D (2012) Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol 12(5):383–396. doi: 10.1038/nri3209
Spaeth EL, Dembinski JL, Sasser AK, Watson K, Klopp A, Hall B, Andreeff M, Marini F (2009) Mesenchymal stem cell transition to tumor-associated fibroblasts contributes to fibrovascular network expansion and tumor progression. PLoS One 4(4):e4992. doi: 10.1371/journal.pone.0004992
Mishra PJ, Humeniuk R, Medina DJ, Alexe G, Mesirov JP, Ganesan S, Glod JW, Banerjee D (2008) Carcinoma-associated fibroblast-like differentiation of human mesenchymal stem cells. Cancer Res 68(11):4331–4339. doi: 10.1158/0008-5472.CAN-08-0943
Xouri G, Christian S (2010) Origin and function of tumor stroma fibroblasts. Semin Cell Dev Biol 21(1):40–46. doi: 10.1016/j.semcdb.2009.11.017
Ostman A, Augsten M (2009) Cancer-associated fibroblasts and tumor growth–bystanders turning into key players. Curr Opin Genet Dev 19(1):67–73. doi: 10.1016/j.gde.2009.01.003
Kalluri R, Zeisberg M (2006) Fibroblasts in cancer. Nat Rev Cancer 6(5):392–401. doi: 10.1038/nrc1877
Hass R, Otte A (2012) Mesenchymal stem cells as all-round supporters in a normal and neoplastic microenvironment. Cell Commun Signal 10(1):26. doi: 10.1186/1478-811X-10-26
Barcellos-de-Souza P, Gori V, Bambi F, Chiarugi P (2013) Tumor microenvironment: bone marrow-mesenchymal stem cells as key players. Biochim Biophys Acta 1836(2):321–335. doi: 10.1016/j.bbcan.2013.10.004
Kucerova L, Matuskova M, Hlubinova K, Altanerova V, Altaner C (2010) Tumor cell behaviour modulation by mesenchymal stromal cells. Mol Cancer 9:129. doi: 10.1186/1476-4598-9-129
Li HJ, Reinhardt F, Herschman HR, Weinberg RA (2012) Cancer-stimulated mesenchymal stem cells create a carcinoma stem cell niche via prostaglandin E2 signaling. Cancer Discov 2(9):840–855. doi: 10.1158/2159-8290.CD-12-0101
Klopp AH, Gupta A, Spaeth E, Andreeff M, Marini F 3rd (2011) Concise review: dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth? Stem Cells 29(1):11–19. doi: 10.1002/stem.559
Kucerova L, Altanerova V, Matuskova M, Tyciakova S, Altaner C (2007) Adipose tissue-derived human mesenchymal stem cells mediated prodrug cancer gene therapy. Cancer Res 67(13):6304–6313. doi: 10.1158/0008-5472.CAN-06-4024
Kucerova L, Kovacovicova M, Polak S, Bohac M, Fedeles J, Palencar D, Matuskova M (2011) Interaction of human adipose tissue-derived mesenchymal stromal cells with breast cancer cells. Neoplasma 58(5):361–370
Kucerova L, Skolekova S, Matuskova M, Bohac M, Kozovska Z (2013) Altered features and increased chemosensitivity of human breast cancer cells mediated by adipose tissue-derived mesenchymal stromal cells. BMC Cancer 13(1):535. doi: 10.1186/1471-2407-13-535
Martinez C, Hofmann TJ, Marino R, Dominici M, Horwitz EM (2007) Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs. Blood 109(10):4245–4248. doi: 10.1182/blood-2006-08-039347
Kucerova L, Matuskova M, Hlubinova K, Bohovic R, Feketeova L, Janega P, Babal P, Poturnajova M (2011) Bystander cytotoxicity in human medullary thyroid carcinoma cells mediated by fusion yeast cytosine deaminase and 5-fluorocytosine. Cancer Lett 311(1):101–112. doi: 10.1016/j.canlet.2011.07.014
Baek SJ, Kang SK, Ra JC (2011) In vitro migration capacity of human adipose tissue-derived mesenchymal stem cells reflects their expression of receptors for chemokines and growth factors. Exp Mol Med 43(10):596–603. doi: 10.3858/emm.2011.43.10.069
Brooke G, Tong H, Levesque JP, Atkinson K (2008) Molecular trafficking mechanisms of multipotent mesenchymal stem cells derived from human bone marrow and placenta. Stem Cells Dev 17(5):929–940. doi: 10.1089/scd.2007.0156
Shin SY, Nam JS, Lim Y, Lee YH (2010) TNFalpha-exposed bone marrow-derived mesenchymal stem cells promote locomotion of MDA-MB-231 breast cancer cells through transcriptional activation of CXCR3 ligand chemokines. J Biol Chem 285(40):30731–30740. doi: 10.1074/jbc.M110.128124
Rattigan Y, Hsu JM, Mishra PJ, Glod J, Banerjee D (2010) Interleukin 6 mediated recruitment of mesenchymal stem cells to the hypoxic tumor milieu. Exp Cell Res 316(20):3417–3424. doi: 10.1016/j.yexcr.2010.07.002
Liu S, Ginestier C, Ou SJ, Clouthier SG, Patel SH, Monville F, Korkaya H, Heath A, Dutcher J, Kleer CG, Jung Y, Dontu G, Taichman R, Wicha MS (2011) Breast cancer stem cells are regulated by mesenchymal stem cells through cytokine networks. Cancer Res 71(2):614–624. doi: 10.1158/0008-5472.CAN-10-0538
Senst C, Nazari-Shafti T, Kruger S, Honer Zu Bentrup K, Dupin CL, Chaffin AE, Srivastav SK, Worner PM, Abdel-Mageed AB, Alt EU, Izadpanah R (2013) Prospective dual role of mesenchymal stem cells in breast tumor microenvironment. Breast Cancer Res Treat 137(1):69–79. doi: 10.1007/s10549-012-2321-0
Chaturvedi P, Gilkes DM, Wong CC, Luo W, Zhang H, Wei H, Takano N, Schito L, Levchenko A, Semenza GL (2013) Hypoxia-inducible factor-dependent breast cancer-mesenchymal stem cell bidirectional signaling promotes metastasis. J Clin Invest 123(1):189–205. doi: 10.1172/JCI64993
Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, Bell GW, Richardson AL, Polyak K, Tubo R, Weinberg RA (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449(7162):557–563. doi: 10.1038/nature06188
Muehlberg FL, Song YH, Krohn A, Pinilla SP, Droll LH, Leng X, Seidensticker M, Ricke J, Altman AM, Devarajan E, Liu W, Arlinghaus RB, Alt EU (2009) Tissue-resident stem cells promote breast cancer growth and metastasis. Carcinogenesis 30(4):589–597. doi: 10.1093/carcin/bgp036
Bexell D, Gunnarsson S, Tormin A, Darabi A, Gisselsson D, Roybon L, Scheding S, Bengzon J (2009) Bone marrow multipotent mesenchymal stroma cells act as pericyte-like migratory vehicles in experimental gliomas. Mol Ther 17(1):183–190. doi: 10.1038/mt.2008.229
Desai VD, Hsia HC, Schwarzbauer JE (2014) Reversible modulation of myofibroblast differentiation in adipose-derived mesenchymal stem cells. PLoS One 9(1):e86865. doi: 10.1371/journal.pone.0086865
Ronnov-Jessen L, Petersen OW (1996) A function for filamentous alpha-smooth muscle actin: retardation of motility in fibroblasts. J Cell Biol 134(1):67–80
Sugimoto H, Mundel TM, Kieran MW, Kalluri R (2006) Identification of fibroblast heterogeneity in the tumor microenvironment. Cancer Biol Ther 5(12):1640–1646
Bagley RG, Weber W, Rouleau C, Yao M, Honma N, Kataoka S, Ishida I, Roberts BL, Teicher BA (2009) Human mesenchymal stem cells from bone marrow express tumor endothelial and stromal markers. Int J Oncol 34(3):619–627
Suzuki K, Sun R, Origuchi M, Kanehira M, Takahata T, Itoh J, Umezawa A, Kijima H, Fukuda S, Saijo Y (2011) Mesenchymal stromal cells promote tumor growth through the enhancement of neovascularization. Mol Med 17(7–8):579–587. doi: 10.2119/molmed.2010.00157
Pricola KL, Kuhn NZ, Haleem-Smith H, Song Y, Tuan RS (2009) Interleukin-6 maintains bone marrow-derived mesenchymal stem cell stemness by an ERK1/2-dependent mechanism. J Cell Biochem 108(3):577–588. doi: 10.1002/jcb.22289
Korkaya H, Wicha MS (2013) Breast cancer stem cells: we’ve got them surrounded. Clin Cancer Res 19(3):511–513. doi: 10.1158/1078-0432.CCR-12-3450
Schmitt E, Bopp T (2012) Amazing IL-9: revealing a new function for an “old” cytokine. J Clin Invest 122(11):3857–3859. doi: 10.1172/JCI65929
Bourin P, Bunnell BA, Casteilla L, Dominici M, Katz AJ, March KL, Redl H, Rubin JP, Yoshimura K, Gimble JM (2013) Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: a joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT). Cytotherapy 15(6):641–648. doi: 10.1016/j.jcyt.2013.02.006
Furukawa S, Soeda S, Kiko Y, Suzuki O, Hashimoto Y, Watanabe T, Nishiyama H, Tasaki K, Hojo H, Abe M, Fujimori K (2013) MCP-1 promotes invasion and adhesion of human ovarian cancer cells. Anticancer Res 33(11):4785–4790
Jin HJ, Nam HY, Bae YK, Kim SY, Im IR, Oh W, Yang YS, Choi SJ, Kim SW (2010) GD2 expression is closely associated with neuronal differentiation of human umbilical cord blood-derived mesenchymal stem cells. Cell Mol Life Sci CMLS 67(11):1845–1858. doi: 10.1007/s00018-010-0292-z
Cook D, Genever P (2013) Regulation of mesenchymal stem cell differentiation. Adv Exp Med Biol 786:213–229. doi: 10.1007/978-94-007-6621-1_12
Oldershaw RA, Hardingham TE (2010) Notch signaling during chondrogenesis of human bone marrow stem cells. Bone 46(2):286–293. doi: 10.1016/j.bone.2009.04.242